[go: up one dir, main page]

MX2012005595A - Proteina marcadora para diabetes de tipo 2. - Google Patents

Proteina marcadora para diabetes de tipo 2.

Info

Publication number
MX2012005595A
MX2012005595A MX2012005595A MX2012005595A MX2012005595A MX 2012005595 A MX2012005595 A MX 2012005595A MX 2012005595 A MX2012005595 A MX 2012005595A MX 2012005595 A MX2012005595 A MX 2012005595A MX 2012005595 A MX2012005595 A MX 2012005595A
Authority
MX
Mexico
Prior art keywords
diabetes
type
marker protein
provides
antibodies directed
Prior art date
Application number
MX2012005595A
Other languages
English (en)
Inventor
Haiyan Wang
Thomas Schindler
Hugues Matile
Cristiano Migliorini
Laura Badi
Martin Ebeling
Jacob Sabates Bellver
Elena Sebokova
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2012005595A publication Critical patent/MX2012005595A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención provee una proteína marcadora para la detección temprana de diabetes de tipo 2, anticuerpos dirigidos a la proteína marcadora y su uso en el método de diagnóstico para diabetes de tipo 2 y en el desarrollo de fármaco.
MX2012005595A 2009-11-26 2010-11-23 Proteina marcadora para diabetes de tipo 2. MX2012005595A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09177238 2009-11-26
PCT/EP2010/067963 WO2011064179A1 (en) 2009-11-26 2010-11-23 Marker protein for type 2 diabetes

Publications (1)

Publication Number Publication Date
MX2012005595A true MX2012005595A (es) 2012-05-29

Family

ID=41462481

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012005595A MX2012005595A (es) 2009-11-26 2010-11-23 Proteina marcadora para diabetes de tipo 2.

Country Status (14)

Country Link
US (1) US20120276561A1 (es)
EP (1) EP2504361A1 (es)
JP (1) JP5698254B2 (es)
KR (1) KR101363682B1 (es)
CN (1) CN102639563A (es)
AU (1) AU2010323235B2 (es)
BR (1) BR112012012213A2 (es)
CA (1) CA2779381A1 (es)
IL (1) IL219102A0 (es)
MX (1) MX2012005595A (es)
NZ (1) NZ599173A (es)
RU (1) RU2012126312A (es)
SG (1) SG181053A1 (es)
WO (1) WO2011064179A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025518482A (ja) * 2022-05-11 2025-06-17 ドイチェス クレブスフォルシュンクスツェントルム スチフトゥング デス エッフェントリヒェン レヒツ 膵臓癌および２型糖尿病のための診断マーカーとしてのｂｍｍｆ１ ｒｅｐタンパク質の使用
CN117843807B (zh) * 2023-12-08 2024-10-25 深圳市龙华区人民医院 一种tmem27融合蛋白、全人源单链抗体及其筛选方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
WO1993006217A1 (en) 1991-09-19 1993-04-01 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
US5789199A (en) 1994-11-03 1998-08-04 Genentech, Inc. Process for bacterial production of polypeptides
US5840523A (en) 1995-03-01 1998-11-24 Genetech, Inc. Methods and compositions for secretion of heterologous polypeptides
WO1999001020A2 (en) * 1997-07-01 1999-01-14 Human Genome Sciences, Inc. 19 human secreted proteins
US7097989B2 (en) * 2001-11-23 2006-08-29 Syn X Pharma, Inc. Complement C3 precursor biopolymer markers predictive of type II diabetes
US7557196B2 (en) * 2001-12-07 2009-07-07 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services hGC-1, a gene encoding a member of the olfactomedin-related protein family
RU2008150483A (ru) * 2006-05-22 2010-06-27 Клиникал Дженомикс Пти Лтд (Au) Способ выявления
WO2008067065A2 (en) * 2006-10-19 2008-06-05 Shiv Srivastava Methods, kits, and systems for diagnosing and prognosing prostate cancer using secreted biomarkers
JP5467256B2 (ja) * 2008-01-11 2014-04-09 国立大学法人広島大学 消化器癌検出用血清腫瘍マーカー、消化器癌検出キット、および消化器癌検出方法

Also Published As

Publication number Publication date
EP2504361A1 (en) 2012-10-03
AU2010323235B2 (en) 2013-05-23
RU2012126312A (ru) 2014-01-10
KR101363682B1 (ko) 2014-02-14
BR112012012213A2 (pt) 2017-01-10
KR20120098809A (ko) 2012-09-05
NZ599173A (en) 2013-06-28
JP2013512421A (ja) 2013-04-11
JP5698254B2 (ja) 2015-04-08
SG181053A1 (en) 2012-07-30
WO2011064179A1 (en) 2011-06-03
US20120276561A1 (en) 2012-11-01
AU2010323235A1 (en) 2012-05-10
IL219102A0 (en) 2012-06-28
CN102639563A (zh) 2012-08-15
CA2779381A1 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
MX383886B (es) Anticuerpo anti-trop-2 humano que tiene una actividad antitumoral in vivo.
PH12012502231A1 (en) Anti-human trop-2 antibody having antitumor activity in vivo
MX347893B (es) Conjugados de farmaco y anticuerpo humano contra factor de tejido.
AU2012356133A8 (en) A rapid quantitative assay to measure CFTR function in a primary intestinal culture model
MY171841A (en) Antibody formulation
MX2010003884A (es) Anticuerpo dirigido a la proteina lecitina similar a inmunoglobulina de union a acido sialico-15 relacionado con osteoclastos.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
TW201129381A (en) Antibodies against human CSF-1R and uses thereof
MX345092B (es) Anticuerpos anti-tau humanos,.
WO2010017515A3 (en) Breast cancer specific markers and methods of use
WO2011015602A3 (en) Lung cancer biomarkers
TN2014000120A1 (en) Cd27l antigen binding proteins
NO20083891L (no) Anti-5T4 antistoffer og anvendelser derav
IN2015DN02349A (es)
UA106194C2 (ru) Диагностика и лечение рака с применением антитела к ereg
WO2009113814A3 (ko) 간암 진단용 단백질성 마커
UA101167C2 (ru) Фармацевтическая композиция, предназначенная для лечения глазной болезни
WO2012078623A3 (en) Biomarkers for monitoring treatment of neuropsychiatric diseases
ATE553778T1 (de) Für humanes hepcidin spezifische antikörper
WO2013093115A3 (de) Markersequenzen für brustkrebs und deren verwendung
NZ592994A (en) Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene
GB2497453A (en) Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV
WO2012075023A3 (en) Neoantibodies for diagnosing tissue injury
WO2012049225A3 (de) Markersequenzen für systemischer lupus erythematodes und deren verwendung
WO2010000874A3 (de) Markersequenzen für prostataentzündungserkrankungen, prostatakarzinom und deren verwendung

Legal Events

Date Code Title Description
FG Grant or registration